---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-082809"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2024-09-27T23:59:59+00:00"
generated_at: "2026-05-31T01:09:25.749964+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Citius extends employment agreement with EVP Holubiak and insider warrants to 2025

## Summary
- Myron Holubiak's employment term extended by one year to Oct 31, 2025; all other terms unchanged.
- Investor warrants for 2,793,297 shares at $0.77 held by CEO Mazur and EVP Holubiak extended to Sept 27, 2025.
- Underwriter warrants for 194,358 shares at $1.11875 extended to same date, held by Wainwright representatives.
- Full exercise of all extended warrants would yield ~$2.4M in cash proceeds to the company.

## SEC filing metadata
- accession: 0001213900-24-082809
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2024-09-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390024082809/0001213900-24-082809-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390024082809/ea0215927-8k_citiuspharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-082809
- JSON: https://secwatch.observer/filing/0001213900-24-082809.json
- Plain text: https://secwatch.observer/filing/0001213900-24-082809.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.